AK
Abhijeet Kumar
About Abhijeet Kumar
Data last updated:
Abhijeet Kumar is a Director at Bsvlmp Pharmaceuticals Private Limited (since 2017) and Director at Bsvlmp Lifesciences Private Limited (since 2021). The companies operate in Trading and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹42 Lakh; the largest is Bsvlmp Pharmaceuticals Private Limited at ₹35.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Feb 2017 | 2017 | ₹35.8 Lakh (FY 2025) | Active | |
| Director | 03 Sep 2021 | 2021 | ₹6.2 Lakh (FY 2024) | Active |
Board colleagues of Abhijeet Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Uma Devi | 08765452 | Bsvlmp Pharmaceuticals Private Limited , Bsvlmp Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhijeet Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhijeet Kumar
Abhijeet Kumar currently holds 2 directorships: Bsvlmp Pharmaceuticals Private Limited (Director, since 07 Feb 2017, revenue ₹35.8 Lakh (FY 2025)); Bsvlmp Lifesciences Private Limited (Director, since 03 Sep 2021, revenue ₹6.2 Lakh (FY 2024)).
Abhijeet Kumar was first appointed on 07 Feb 2017 as Director at Bsvlmp Pharmaceuticals Private Limited. The most recent appointment on record is 03 Sep 2021 at Bsvlmp Lifesciences Private Limited.
The 2 current companies of Abhijeet Kumar that report revenue have a combined latest revenue of ₹42 Lakh: Bsvlmp Pharmaceuticals Private Limited ₹35.8 Lakh (FY 2025); Bsvlmp Lifesciences Private Limited ₹6.2 Lakh (FY 2024).
The current boards of Abhijeet Kumar's companies include Uma Devi (Bsvlmp Pharmaceuticals Private Limited).